Goed stuk van @ellaweggen.bsky.social waarin ze uitlegt waarom voorwaarden aan publieks financiering van medicijn onderzoek toegang tot medicijnen kan verbeteren: www.nrc.nl/nieuws/2026/...
Ellen 't Hoen
Ellen 't Hoen
@ellenthoen.bsky.social
X-Twitter refugee looking for a safer place. I spend most of my time working on access to medicines and intellectual property at www.medicineslawandpolicy.org. If not, I cook.
2.7K followers143 following120 posts
Here is the solution to the stalled WHO PABS negotiations, needed to clear the last roadblock to ratification and entering into force of the Pandemic Agreement. @jamielove.bsky.social www.keionline.org/41368
This morning at the opening session of the 6th session of the WHO PABS negotiations we supported this proposal made by @keiwashdc.bsky.social #pandemicagreement
Ellen 't Hoen reposted
On the Occasion of the #G7 Summit An Open Letter to the Leaders of the G7, the G20, BRICS & All Nations On finalizing the Pathogen Access & Benefit-Sharing annex of the WHO Pandemic Agreement ⬇️ @lulaoficialbluesky.bsky.social President of #Brazil Dr Tedros Adhanom Ghebreyesus DG of @who.int
Ellen 't Hoen reposted
FT Exclusive: Four months after its establishment, the organisation’s financial fund set up by the World Bank has received no money from donors, according to four people familiar with the matter. ft.trib.al/LQLpKfw
This is an interesting new @medicinespatentpool.org licence. Generic manufacturers, anywhere in the world, interested in producing baloxavir marboxil should contact the MPP through its expression of interest portal: medicinespatentpool.org/partners/how...
Today at #WHA79, MPP and Roche celebrated the signing of a public health-oriented voluntary licence agreement for baloxavir marboxil, an #influenza antiviral treatment recommended by @who.int. Read the announcement: bit.ly/4wwZsW1 @unitaid.bsky.social @drduneton.bsky.social
Our blog on the state of play in the @who.int PABS negotiations. medicineslawandpolicy.org/2026/05/worl...
Ellen 't Hoen reposted
📢 Maak #geengeheim van mijn medicijn. @ellenthoen.bsky.social is expert patentrecht en directeur van @medslawpolicy.bsky.social. Zij ondertekende de open brief aan de regering en Tweede Kamer voor meer transparantie in de farma-sector. ✍ Lees en onderteken de brief op www.wemos.org/geengeheim.
Ellen 't Hoen reposted
Just out: our overview of over two decades of the use of TRIPS flexibilities to access medicines in BMJ Global Health gh.bmj.com/content/11/1...
Met dank aan @wemos.org om mij hierbij te betrekken. Transparantie is de basis van een democratische samenleving en het vertrouwen in de instituties en bedrijven die er actief zijn. Dat geldt ook voor de farmaceutische industrie.
💊💰🔎 De farma-industrie is uitzonderlijk en vraagt daarom om uitzonderlijke regulering. Transparantie is nodig voor eerlijke medicijnprijzen. Aldus @ellaweggen.bsky.social van Wemos, @ellenthoen.bsky.social en @katperehudoff.bsky.social in @volkskrant.nl. Lees: www.volkskrant.nl/columns-opin...
Meanwhile: US has now left the @who.int “The U.S. flag had been removed from outside the WHO headquarters in Geneva on Thursday, according to witnesses.” www.reuters.com/business/hea...
Ellen 't Hoen reposted
US pharma threaten to withhold products from Europe over prices giftarticle.ft.com/giftarticle/...
Nice tribute to David Mitchell, a US drug pricing advocate who recently passed away. @statnews.com www.statnews.com/2026/01/05/d...
Ellen 't Hoen reposted
Here is my end of the year blog with a highly biased listing of noteworthy medicines law and policy events of 2025: medicineslawandpolicy.org/2025/12/wrap...
I am looking forward to being part of the launch event of the Centre on Knowledge Governance tonight at the @gvagrad.bsky.social docs.google.com/document/d/1...
Ellen 't Hoen reposted
Ellen 't Hoen reposted
“Transitioning to self-reliance sounds good but what is happening today is not a transition. It is a shock to the system of which the most vulnerable will carry the brunt”, says @ellenthoen.bsky.social in a new @thelancet.com here:
Ellen 't Hoen reposted
France is killing it - net price transparency now, ammendment tabled and adopted ! @healthlawadamh.bsky.social @mattherder.bsky.social
Important development in France for those following #pharma #transparency. Socialist MPs have proposed an amendment to the 2026 Social Security Financing Bill that could redefine transparency in how medicines are financed and priced. /1🧵 www.assemblee-nationale.fr/dyn/17/amend...
Fully support this morning’s statement by @theindpanel.bsky.social at the #PABS talks at the WHO. It relates to the news broken by @healthpolicywatch.bsky.social that the US is seeking access to pathogen information in exchange for health funding. healthpolicy-watch.news/exclusive-us...
This am @theindpanel.bsky.social made a statement to #IGWG3 concerning bilateral health deals: "...these bilateral agreements will undermine the multilateral system. They will bypass the WHO, and the foundations of solidarity and equity we have been trying to build here." tinyurl.com/mr4dyr54
Last chance to register for the Amsterdam Medicines Justice Conference. registration closes tomorrow: www.aanmelder.nl/medicinesjus...
The @wto.org just published its 2025 World Trade Report on trade and AI to the benefit for all: www.wto.org/english/res_...
Because “contraception is not life-saving” www.nytimes.com/2025/09/11/h...
Next week, at the @who.int the second meeting of the Intergovernmental Working Group (IGWG) tasked with negotiating the PABS Instrument will take place. We just published this brief on the subject: medicineslawandpolicy.org/2025/09/who-...
The WHO Foundation should clean up its act. And so should member states by supporting the @who.int with core financing. www.theguardian.com/world/2025/s...
GLP-1 drugs have been on the Medicines Patent Pool priority list for a while. Time for the companies to come forward now @who.int labeled them essential @thirugeneva.bsky.social @medicinespatentpool.org
On Sept 5th, @who.int listed GLP-1 drugs on its Essential Medicines List. This listing covers about 75% of the 2.1 m lives saved per year in the lower estimate of the model David Brook and I developed. See the details on the screenshot below from our preprint: www.medrxiv.org/content/10.1... 1/n
Here is our blog on the new WHO Essential Medicines List : medicineslawandpolicy.org/2025/09/trea...
The WHO just published its new Model List of Essential Medicines list. Pleased to see cystic fibrosis meds included. Thanks to the great work of the Right to Breathe campaign. However, Vertex's high prices will continue to be a barrier. www.righttobreathe.net/post/a-huge-...
Not sure that this will do a great deal for increasing confidence in vaccines. www.statnews.com/2025/09/03/p...
Ellen 't Hoen reposted
Ellen 't Hoen reposted
💊💰 In een opiniestuk voor @zorgvisie.bsky.social betoogt @ellaweggen.bsky.social van Wemos dat de overheid nu eindelijk grenzen moet stellen aan prijzen van nieuwe medicijnen. Buitensporige medicijnprijzen verdringen andere belangrijke zorg. Lees: www.zorgvisie.nl/blog/opinie-...
Ellen 't Hoen reposted
This should be an interesting panel on voluntary licensing and socially responsible licensing by academia. English/Spanish translation will be available.
Mesa Redonda: Licenciamiento Voluntario y Socialmente Responsable desde las Universidades. Exploraremos cómo las universidades pueden impulsar una transferencia tecnológica más equitativa mediante licencias voluntarias con enfoque social. Link para inscripción previa us06web.zoom.us/webinar/regi...
on.ft.com/4m1YquY US rejects World Health Organization pandemic response measures (this refers to the amendements to the International Health Regulations)
Ellen 't Hoen reposted
Save the Children suspends BCG partnership over Gaza work https://on.ft.com/40JPe67
Naar verwachting doet morgen de rechtbank uitspraak ik de zaak die de Stichting Farma Ter Verantwoording heeft aangespannen tegen AbbVie vanwege een te hoge prijs voor het medicijn Humira (adalimumab). www.nrc.nl/nieuws/2025/...
He is a danger to the world’s children’s health www.nytimes.com/2025/06/25/h...
As if high medicines prices and inequitable access is not an issue in the EU ….
Today at the Human Rights Council informal, the European Union asked to delete PP35 in the draft right to health resolution because it presented a "distorted view" of access barriers. @arianna-s.bsky.social @hai-org.bsky.social @ellenthoen.bsky.social @wemos.org
I just published a brief blog on the USFDA's approval of long-acting lenacapavir for #PrEP and the potential to end HIV: medicineslawandpolicy.org/2025/06/fda-...
Just out: the latest @gvagrad-ghc.bsky.social Snapshots on the @who.int Pandemic Agreement with my contribution on the Agreement's provisions for technology transfer. www.governingpandemics.org/gp-snapshot
Ellen 't Hoen reposted
Featuring Dr. Anban Pillay, Michelle Childs, Roz Scourse, Jaume Vidal, and James Love. Moderated by Dr Tido von Schoen-Angerer. #WHA78 @keiwashdc.bsky.social
The EU has agreed to an EU-wide mechanism for compulsory licensing to access technologies needed in crisis situations. Ironically, a day after the WHO pandemic agreement was adopted during which negotiations the EU objected vigorously to non-voluntary measures. www.europarl.europa.eu/news/en/pres...
Ellen 't Hoen reposted
🔎💊💰 Out now: our joint report with @hai-org.bsky.social on the status of implementation of WHA resolution 72.8 on #transparency of pharmaceutical markets. What have countries done or not done & what are good practices they can learn from? ➡️ Read the report: www.wemos.org/transparency... #WHA78
Ellen 't Hoen reposted
Replying to @thirugeneva.bsky.social
"The draft text of the WHO Pandemic Agreement1 is submitted to the Seventy-eighth World Health Assembly for adoption in accordance with Article 19 of the Constitution of the World Health Organization," (1/2) #WHA78 #PandemicAccord @who.int @jamielove.bsky.social @ellenthoen.bsky.social